Relevant to our upcoming class investment proposal discussion, note that rumors have Johnson & Johnson (JNJ) making a bid for Swiss medical device maker Synthes. The chatter places the deal at about $20 billion.
JNJ's business model is grounded in acquisitions. The company has made more than 30 material deals in the last 15 years. However, most of JNJ purchases are on the small side; only a few have exceeded $2 billion.
Should the Sunthes purchase rumors become reality, it would be the largest acquisition in JNJ history.
position in JNJ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.